Nexalin Technology (NXL) EPS (Diluted) Growth (3y) (2025 - 2026)

Nexalin Technology (NXL) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -6.43%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 7.66%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 3.09%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 62.91%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 63.42%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 30.57%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 29.56%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Nexalin Technology 9.32 Mn 6.61 Mn 13,133.00 -0.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.99%
Dec 31, 2025 -1.88%
Sep 30, 2025 -29.77%
Jun 30, 2025 -3.05%